Bilal Khan

Bilal Khan

Auto-generated profile, based on publicly available information

Bilal Khan

Department of Human Nutrition, Faculty of Nutrition Sciences, The University of Agriculture Peshawar, Pakistan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Italian Journal of Food Science
Verified
Journal Article
Open access
PDF file
MMMaria Munir
Maria Munir
IKImran Khan
Imran Khan
NANayef Shabbab Almutairi
Nayef Shabbab Almutairi
AAAeshash Hamdan Almutairi
Aeshash Hamdan Almutairi
BKBilal Khan
Bilal Khan
NMNajma Mehboob
Najma Mehboob
Moringa leaf powder has demonstrated beneficial effects on body weight, lipid profiles, and blood pressure in animal studies. However, research on the impact of moringa on these parameters in humans is limited. Therefore, the aim of this study was to examine the effects of moringa on body weight, glycemic status, lipid profile, and blood pressure in human subjects. The study was designed as a randomized controlled parallel clinical trial. A total of 40 overweight, hyperlipidemic subjects (both sexes), aged 30 to 60 years, were included. Participants were assigned to either the moringa group (n=20) or the control group. The moringa group received capsules containing 0.5 g of powdered moringa leaves, while the control group received capsules containing 0.5 g of corn starch, both administered twice a day for 12 weeks. Additionally, both groups were instructed to engage in moderate-intensity physical activity for 40 to 60 minutes. Anthropometric measurements, including weight, BMI, and waist circumference, were taken at baseline and after 12 weeks of intervention. Dietary intake was assessed using the 24-hour dietary recall method at baseline and at the end of the intervention. Venous blood (5 ml) was collected at both time points to determine biochemical parameters, including lipid profile and blood glucose levels. Blood pressure was measured with a sphygmomanometer at baseline and after 12 weeks of intervention. The findings revealed a significant reduction in carbohydrate, energy, and cholesterol intake in the moringa group compared to baseline values. Body weight, BMI, and waist circumference (WC) were significantly lower (P≤0.05) in the treatment group than in the control group. Additionally, there were significant differences (P≤0.05) in blood pressure, triglyceride levels, and LDL and HDL cholesterol levels between the treatment and control groups. The findings of this study indicated that a 1 g dose of moringa over 12 weeks effectively reduced body weight, blood pressure, triglycerides, and LDL and HDL cholesterol levels, while a nonsignificant reduction in total cholesterol was observed in overweight subjects with hyperlipidemia. Therefore, moringa may serve as a complementary treatment alongside existing therapies to improve lipid profiles in hyperlipidemic patients.